<p>Compounds of formula (I) are disclosed, wherein the substituents are defined herein. The compounds are used in the manufacture of medicaments for the treatment of disorders associated with 5HT2C receptor modulation.</p>
申请公布号
NZ516031(A)
申请公布日期
2003.10.31
申请号
NZ20000516031
申请日期
2000.06.15
申请人
BRISTOL-MYERS SQUIBB PHARMA COMPANY
发明人
ROBICHAUD, ALBERT J;LEE, TAEKYU;DENG, WEI;MITCHELL,IAN S;YANG, MICHAEL GUANG;HAYDAR, SIMON;CHEN, WENTING;CCLUNG, CHRISTOPHER D;CAVELLO, EMILIE J B;ZAWROTNY, DAVIDM
